Dec. 8 Event: Unpacking the Prescription Drug Provisions of the Build Back Better Act
As the Build Back Better Act shifts from the House to the Senate, there’s considerable interest in provisions that would lower the cost of prescription drugs.
View the Latest: Prices
Filter
-
-
Ongoing Challenges with Hospital Price Transparency
Issue BriefThis analysis examines transparency data currently shared by hospitals to comply with federal law and finds that they are messy, inconsistent and confusing, making it challenging if not impossible for patients or researchers to use them to compare prices. Many of these shortcomings stem from a lack of specificity in the requirements for what hospitals must report.
-
Analysis: Inconsistencies Within Hospital Price Transparency Data Make Cost Comparisons Difficult
News ReleaseSince 2021, federal law has required hospitals to publicly post information about their standard prices and negotiated discount rates for common health services to encourage consumers to compare prices and to promote competition.
-
Ten Things to Know About Consolidation in Health Care Provider Markets
News ReleaseMergers and acquisitions involving hospitals and other health care providers are drawing attention from federal and state regulators, including the Federal Trade Commission, and policymakers amid concerns that such consolidations can reduce competition and contribute to the high costs of health care.
-
Why Data on Health-Care Price Variation Doesn’t Itself Solve the Problem
From Drew AltmanIn this column for The Wall Street Journal's Think Tank, Drew Altman discusses a new Blue Cross Blue Shield Association report on “extreme price variation” in health care services and the limits of consumer information as a solution to the problem.
-
COVID-19 Test Prices and Payment Policy
Issue BriefThis analysis examines list prices for COVID-19 testing at the largest hospitals in every state and finds they range widely from $20 to $850. Federal law now requires private insurers to cover COVID-19 tests at no cost to the patient and provides funding for people without health insurance.
-
Webinar: How Might the Pandemic Affect Health Premiums, Utilization, and Outcomes in 2021 and Beyond?
Event Date:EventAs the coronavirus pandemic enters its eighth month, we are still facing uncertainty about what the long-term impact of the crisis will be for the health sector, and for patients. However, the extent to which costs grow, and how the burden is distributed across payers, programs, individuals, outcomes, and geography are still very much unknown.
-
What are the recent and forecasted trends in prescription drug spending?
FeatureThis slideshow looks at past, present and future trends in prescription drug spending with a focus on the role of specialty drugs.
-
Health of the Healthcare System: An Overview
FeatureThis slideshow accompanies the video, “Health of the Healthcare System,” a diagnostic look at the state of the U.S. healthcare system. It compares the United States to other countries in four key areas: health, quality of health care, cost of care, and accessibility.
-
Why Higher Drug Costs Are Consumers’ Biggest Cost Worry
From Drew AltmanIn this column for The Wall Street Journal's Think Tank, Drew Altman discusses why public concern over drug prices is the “tip of the iceberg” representing broader concerns about out-of-pocket health care costs.